Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ARLZ

Aralez Pharmaceuticals (ARLZ) Stock Price, News & Analysis

Aralez Pharmaceuticals logo

About Aralez Pharmaceuticals Stock (NASDAQ:ARLZ)

Advanced Chart

Key Stats

Today's Range
$0.03
$0.03
50-Day Range
N/A
52-Week Range
$0.02
$2.98
Volume
N/A
Average Volume
5.13 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ARLZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aralez Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ARLZ Stock News Headlines

Adrian Adams's Net Worth
Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.
Amneal Pharmaceuticals, Inc. (AMRX)
Aveo Pharmaceuticals
MGC Pharmaceuticals Ltd (MXCM)
See More Headlines

ARLZ Stock Analysis - Frequently Asked Questions

Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) released its earnings results on Thursday, November, 9th. The company reported ($0.37) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.39) by $0.02. The business's quarterly revenue was up 78.7% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aralez Pharmaceuticals investors own include Magnegas Applied Tchnlgy Sltns (MNGA), Redhill Biopharma (RDHL), Synergy Pharmaceuticals (SGYP), TransEnterix (TRXDW), Novavax (NVAX), Inovio Pharmaceuticals (INO) and Liquidmetal Technologies (LQMT).

Company Calendar

Last Earnings
11/09/2017
Today
7/19/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:ARLZ
CIK
1660719
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:ARLZ) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners